{
    "2020-09-07": [
        [
            {
                "time": "2023-09-07",
                "original_text": "深港通十大成交活跃股排名（9月7日）",
                "features": {
                    "keywords": [
                        "深港通",
                        "成交活跃股",
                        "排名"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：董事及高管ZHUYIN一股未减提前终止减持计划",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "董事",
                        "高管",
                        "减持计划",
                        "提前终止"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347)：ZHUYIN决定提前结束减持计划 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "减持计划",
                        "提前结束"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "创业板已无股价低于4元的公司，17只4元股半日最小涨幅为6.29%",
                "features": {
                    "keywords": [
                        "创业板",
                        "股价",
                        "涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347.HK)获摩根士丹利增持20.06万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "摩根士丹利",
                        "增持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物：关注估值切换带来低估值板块投资机遇",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值切换",
                        "投资机遇"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}